ROIS Unveils New Brand Identity at CPHI Milan 2026 Event
In a significant move to enhance its corporate identity, ROIS has announced the launch of its new corporate website, a pivotal step that coincides with its participation in the CPHI Milan 2026 event. This initiative reflects the company’s growth and its commitment to providing customers with advanced Contract Development and Manufacturing Organization (CDMO) capabilities. The unveiling at CPHI Milan promises to bring ROIS’s refreshed brand to life, presenting a brand new exhibition booth, engaging corporate brochures, and dynamic digital content to its audience.
Emphasizing Growth and Commitment
Building on over 50 years of experience with its parent company ROVI, ROIS has evolved into an independent CDMO, enhancing its global manufacturing capabilities through five strategically located manufacturing sites across Europe and the United States. This new identity not only showcases the company’s growth trajectory but also emphasizes its dedication to fostering personalized partnerships with its clients. CEO Javier López-Belmonte stated, "As the CDMO division of ROVI has rapidly expanded, the need for a distinct brand identity for ROIS became clear. The new website exemplifies our modern stance, highlighting our significant capabilities and our family-led, long-term approach to partnerships."
Cutting-Edge Manufacturing Capabilities
ROIS is equipped with an impressive annual capacity of over 800 million units for prefilled syringes, cartridges, and vials. It merges notable expertise in sterile fill-finish processes with advanced specialist capabilities such as cytotoxic manufacturing, lyophilization, and robust OEB5 containment measures. This comprehensive support allows ROIS to cater to an array of complex injectable products including biologics, biosimilars, antibody-drug conjugates (ADCs), peptides, GLP-1's, vaccines, and mRNA therapies. With facilities distributed across multiple regions, ROIS offers its clients the benefit of localized manufacturing flexibility and a singular accountable partner for vast global programs, stretching across more than 75 international markets.
The ROIS Experience at CPHI Milan
During the CPHI Milan event, taking place from October 6 to 8, attendees will have the opportunity to witness the new ROIS branding in action at their exhibition space, complete with updated corporate materials, engaging videos, and digital presentations. The newly launched website,
www.roiscdmo.com, consolidates ROIS’s diverse manufacturing capabilities and integrated service offerings, making it simpler for pharmaceutical and biotech companies to navigate and discover optimal manufacturing solutions that fit their needs.
This launch represents an exciting phase in ROIS's development journey, effectively aligning its global manufacturing scale with the agility and sustainable perspective inherent in family-run businesses. As ROIS steps confidently into the future, their commitment to the pharmaceutical sector and their clients remains steadfast, ensuring a focus on quality and personalized service that defines the company’s ethos.
Meet ROIS at CPHI Milan 2026
For more information and to connect with ROIS, visit their dedicated CPHI Milan event page at www.roiscdmo.com/events/ and discover how ROIS can support your CDMO needs during October 6-8, 2026, at Fiera Milano, Italy, Booth 10C49.